Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Neoplasm Metastasis
×
naptumomab estafenatox
×
Clear all
Filters
3
NCT04880863
2025-03-03
NT-NAP-102-1
NeoTX Therapeutics Ltd.
Phase 2
Completed
38 enrolled
13 charts